Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.


CSE:PHRM - Post by User

Comment by Guytoruleon Oct 28, 2024 11:07am
53 Views
Post# 36285002

RE:RE:RE:RE:Back on track.. (Stop loss selling over)

RE:RE:RE:RE:Back on track.. (Stop loss selling over)Fully Agree Sailor,...Catalyst will be "FDA Approval" and see massive trading volume with share price close to than $ plus range and shortly later followed up with partnership/agreements. Then, over months do see over $2 plus dollars with revenue model forecasts.. Multi-bagger for sure, only if they acquire FDA approval, and/or barring any unforeseeable events. this is a HOLD and accumulate at these low prices. Im in big, and continue to buy at lows of the day. Time will tell...Good Luck to all holding shares. Patience will be rewarded and with a company release on their respond letter will help support share price further and will move the needle..
<< Previous
Bullboard Posts
Next >>